Overall, our findings suggest that Bi-212-MAA can kill breast cancer cells and reduce tumor growth by regulating cell death (Caspase 3) and DNA damage (γH2AX) marker (Figure 5C). This evidence concerns the gene CASP3 and neoplasm.